Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Biochip Stories

28b80b3afd056ced55ecf83240e91ca0
2010-08-04 13:43:43

DNA microarrays are one of the most powerful tools in molecular biology today. The devices, which can be used to probe biological samples and detect particular genes or genetic sequences, are employed in everything from forensic analysis to disease detection to drug development. Now Paul Li and colleagues at Simon Fraser University in Burnaby, Canada have combined DNA microarrays with microfluidic devices, which are used for the precise control of liquids at the nanoscale. In an upcoming...

2010-06-24 11:03:00

BARCELONA, June 24 /PRNewswire/ -- Spanish biotechnology company Progenika Biopharma, specializing in the development of personal medicine technology, has granted Grifols exclusive world-wide distribution rights for its BLOODCHIP® molecular biology products. BLOODCHIP® products are used for genotyping of blood donors to assure the compatibility of blood for transfusion between donor and recipient. Under this agreement, Grifols takes a further step...

2010-06-23 09:13:00

HEIDELBERG, Germany and LEXINGTON, Mass., June 23 /PRNewswire/ -- febit today announced a restructuring as a consequence of its strategic focus on blood-based microRNA biomarker discovery, febit's major business development in 2009/2010, and on partnerships and intellectual property (IP) commercialization. The new focus includes the collaboration and provision of high-end services for clinical researchers in academia, diagnostic companies and the pharma industry. febit's...

2010-04-06 08:00:00

ALBUQUERQUE, N.M., April 6 /PRNewswire/ -- Life BioScience, Inc. (LBSI) has launched a new Life MicroFab(TM) Division that provides a broad range of micro-fabrication services for devices made in APEX(TM) Glass, APEX(TM) Ceramic, Silicon, Pyrex(TM), SOI, Kapton(TM) and other standard materials used in the semiconductor manufacturing process. Its services are targeted at customers seeking convenient and cost efficient solutions for their micro-fabrication needs - whether they are in the...

2010-03-01 09:12:00

LEXINGTON, Mass. and HEIDELBERG, Germany, March 1 /PRNewswire/ -- febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in addition to all of the Homo sapiens microRNAs (miRNA) from miRBase version 14 (www.mirbase.org) is now available for cancer research. The 58 new miRNA sequences were found by deep sequencing in a miRNA discovery study performed on an Applied Biosystems SOLiD 3 sequencing system. All 58 miRNAs have been...

2010-02-17 09:52:00

LEXINGTON, Mass. and HEIDELBERG, Germany, Feb. 17 /PRNewswire/ -- febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida. AGBT is now widely regarded as the premier scientific forum for sharing information about the latest advances in new DNA sequencing technologies and their application to diverse areas in...

2010-01-20 09:42:00

LEXINGTON, Mass., and HEIDELBERG, Germany, Jan. 20 /PRNewswire/ -- The Molecular Genetics Core Facility (MGCF) at Children's Hospital Boston chose febit's HybSelect technology which will enable genetics researchers to conduct the highly economic targeted enrichment of genes of interest for resequencing. In January the core facility will be receiving the Geniom RT Analyzer® from febit to perform HybSelect. "We feel that febit's HybSelect technology will be a powerful tool...

2009-12-16 03:42:00

HAMBURG, Germany, December 16 /PRNewswire/ -- Eppendorf has initiated an import ban for Nanosphere, Inc.'s Verigene(R) and Verigene(R) SP systems for infringement of European patent EP 1 179 180 B2, titled "Method for the identification and/or the quantification of a target compound". The import ban covers any and all imports of the respective products into any country of the European Union. Customs authorities are required to confiscate any violating products. The patent covers...

2009-12-02 17:02:00

NEW YORK, Dec. 2 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html Drug discovery has become an integral and ongoing element of every pharmaceutical company's business strategy. There are a number of new technologies that are...

2009-12-02 09:41:00

LEXINGTON, Mass. and HEIDELBERG, Germany, Dec. 2 /PRNewswire/ -- febit's HybSelect has been recognized as one of the winners of the "Top 10 Innovations of 2009" by The Scientist magazine. The company's automated sequence capture technology for high-throughput sequencing was selected due to its exceptional combinations of invention, vision and utility. The Scientist gathered a panel of expert judges to evaluate a broad range of life science technologies and determined the best innovations...